top of page

LICHEN PLANUS
CURRENTLY ENROLLING TRIALS

1200px-Incyte_logo.svg.png

A Phase 2, Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Open for participants age ≥ 18 with a clinical diagnosis of Lichen Planus with predominant cutaneous involvement.

​

Requirements:

  • Lichen Planus affecting ≤ 20% Body Surface Area (BSA), or less than 20 hand prints (1 hand print = 1%)

 

Further inclusion/exclusion criteria apply. If you think you may qualify, please take our pre-screen assessment.

UPCOMING CLINICAL TRIALS

Don't qualify for any of our trials?

Note: If you are under the age of 18, please have your parent/guardian call us directly at 847-663-8530.

Thanks for submitting!

We begin new trials often. If you do not qualify for our current studies, please leave your information, and we'll keep you updated of any upcoming trials that may be right for you.

bottom of page